New York Business Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New York Business Digest.

Press releases published on May 21, 2026

May 21, 2026

Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations

Indeterminate GlobeNewswire

May 21, 2026

Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026

Indeterminate GlobeNewswire

May 21, 2026

Equus Announces First Quarter Net Asset Value

Indeterminate GlobeNewswire

May 21, 2026

ROSEN, THE FIRST FILING FIRM, Encourages SES AI Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SES

Indeterminate GlobeNewswire

May 21, 2026

North American Construction Group Ltd. Announces Voting Results of Annual and Special Meeting of Shareholders

Indeterminate GlobeNewswire

May 21, 2026

Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology

Indeterminate GlobeNewswire

May 21, 2026

Imperial Announces Voting Results for the Election of Directors

Indeterminate GlobeNewswire

May 21, 2026

Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin

Indeterminate GlobeNewswire

May 21, 2026

Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis

Indeterminate GlobeNewswire

May 21, 2026

Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data

Indeterminate GlobeNewswire

May 21, 2026

ALDX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

Indeterminate GlobeNewswire

May 21, 2026

Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models

Indeterminate GlobeNewswire

May 21, 2026

AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit

Indeterminate GlobeNewswire

May 21, 2026

Legend Biotech Announces Presentations at ASCO 2026

Indeterminate GlobeNewswire

May 21, 2026

Navient declares second quarter common stock dividend

Indeterminate GlobeNewswire

May 21, 2026

Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC

Indeterminate GlobeNewswire

May 21, 2026

Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

May 21, 2026

NVIDIA Announces Upcoming Events for Financial Community

Indeterminate GlobeNewswire

May 21, 2026

Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

May 21, 2026

Canadian Net REIT Announces 2026 First-Quarter Results and a Distribution Increase

Indeterminate GlobeNewswire